UBXN2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.81286146889215E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.21109999806635E-08 |
Normal-vs-Stage2 |
9.69899999999635E-05 |
Normal-vs-Stage3 |
9.4716456899846E-12 |
Normal-vs-Stage4 |
1.58519974924332E-10 |
Stage1-vs-Stage2 |
5.307200E-01 |
Stage1-vs-Stage3 |
9.584600E-03 |
Stage1-vs-Stage4 |
2.122400E-02 |
Stage2-vs-Stage3 |
3.152000E-01 |
Stage2-vs-Stage4 |
3.194200E-01 |
Stage3-vs-Stage4 |
9.552600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.34410260699269E-11 |
Normal-vs-AfricanAmerican |
1.76959999986792E-08 |
Normal-vs-Asian |
5.875200E-01 |
Caucasian-vs-AfricanAmerican |
3.724000E-01 |
Caucasian-vs-Asian |
8.888200E-02 |
AfricanAmerican-vs-Asian |
4.221600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.68864922045486E-12 |
Normal-vs-Female |
2.06900000465637E-08 |
Male-vs-Female |
1.074810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.64620000000704E-05 |
Normal-vs-Age(41-60Yrs) |
4.44320003012422E-09 |
Normal-vs-Age(61-80Yrs) |
1.33200117602428E-11 |
Normal-vs-Age(81-100Yrs) |
1.840410E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.579600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.546000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.236400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.287450E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.680400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.506200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.709400E-01 |
Normal-vs-Grade 2 |
3.37629999958011E-07 |
Normal-vs-Grade 3 |
1.74293912635903E-12 |
Normal-vs-Grade 4 |
1.30219945937426E-10 |
Grade 1-vs-Grade 2 |
2.321800E-01 |
Grade 1-vs-Grade 3 |
7.236200E-03 |
Grade 1-vs-Grade 4 |
8.300700E-03 |
Grade 2-vs-Grade 3 |
1.964600E-03 |
Grade 2-vs-Grade 4 |
9.162200E-03 |
Grade 3-vs-Grade 4 |
5.413400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.25169999984654E-07 |
Normal-vs-ccB subtype |
7.38119565468764E-11 |
ccA subtype-vs-ccB subtype |
2.622000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.02100036495301E-10 |
Normal-vs-N1 |
7.205600E-04 |
N0-vs-N1 |
8.409000E-01 |
|
|